Journal of Medical Microbiology 1998: Vol 47 Index

15 Pages·1998·0.99 MB·English

INDEX OF SUBJECTS FOR VOLUME 47
Abscesses Soulsby report, 749
microbiology of, 1075 S. pneumoniae causing invasive disease, 17
Acatuhamoeha spp. surveillance, 751, 137
in human disease, 8 vancomycin, and enterococci, 849
isolation and identification, 9, 11 Antibiotics and other antimicrobial substances
Acinetohacter spp. acyclic nucleoside phosphonates. 1
antibiotic resistance in hospitals. 1037 animal bite wounds and. 95
epidemiology of aminoglycoside resistance, 455 avoparcin, implieations of use, 849
ActinohaciJIus actinomycetemcomitans chemoprophylaxis of outbreak strain of N. meningitidis, 993
lipopolysaccharide, 569 comparative suseeptibilities of mycoplasmas, 1115
transport and isolation, 743 current status and usage. 751
two types of immune response in periodontitis, 569 drug metabolism in children. 975
Acyclic nucleoside phosphonates in induction of cytokine release by 5. aureus, 533
chemotherapy of DNA and retrovirus infections. 1 influence of gentamicin on growth of L. monocytogenes, 211
Adefovir in management of cystic fibrosis, 969
antiviral activity, 1 natural susceptibility of Providencia spp., 629
Adenoviruses nebulised, 970
gastro-enteritis in children, 963 penicillin in meningococcal disease. 961
infections in immunocompromised patients, 561 prospects for new agents. 751
typing, and epidemic keratoconjunctivitis. 91 in surgical wound infection in Africa, 471
Adherence susceptibility of Nocardia spp.. 85
group A streptococci to epithelial cells, 899 therapy in children. 975
H. pylori to gastric epithelial cells, 505 Antibodies
inhibition by L acidophilus biosurfactant, 1081 against A. actinomycetemcomitans, 569
MRSA to plastic and cell cultures, 705 against B. hurgdorferi, llTi
of nosocomial 5. marcescens strains, 1105 against C. pneumoniae, 615
P. aeruginosa to tracheal eells, 129 against H. pylori, 1123
uropathogenic bacteria and yeasts to silicone rubber, 1081 against P. aeruginosa, 295
Aeromonas spp. against S. aureus, 217
A. caviae type IV pilus, 527 against S. pilosicoli, 317
A. hydrophila collagen-binding protein, 417 against streptococcal heat-shock proteins, 711
epidemiological typing of A. hydrophila. 499 anti-phosphatidylcholine, in brucellosis, 49
Agglutination see also Monoclonal antibodies
microplate test for Legionnaires’ disease, 325 Antigens
Aggregation 25-kDa OMP of B. melitensis. 39
properties of M. catarrhalis, 159 of A. actinomycetemcomitans, 569
AIDS patients bacterial conjugate vaccines and, 563
antibiotic susceptibility of associated mycoplasmas, 1115 brucella, in diagnosis of brucellosis, 169
detection of mycoplasmas in respiratory tract specimens, 983 copro-antigens of Echinococcus spp.. 281
haemolytic activity of M. avium isolates, 365 of M. hominis, 659
JC virus infection in, 733 of N. meningitidis. 993
Amikacin outer-membrane, of M catarrhalis, 159
resistance of Enterobacteriaceae, 1019 P. carinii, production in rat model. 543
Aminoglycosides of S. marcescens. 1097
resistance of Acinetohacter spp., 455 of S. pilosicoli, 317
resistance of Enterobacteriaceae, 1019 of .5. pyogenes, 655
Amoebae, ‘free-living’ Antiviral agents
human disease, 5 acyclic nucleoside phosphonates. I
isolation and identification, 5 Apoptosis
symbiosis with Legionella spp., 11, 937, 939 E enterocolitica-inAuccd. AAl
Anaerobes Arthritis, septic, 717
black-pigmented, and bacteriocin activity, 585 Astrovirus
in liver and spleen abscesses, 1075 gastro-enteritis in children. 963
Animals see Bite wounds. Guinea-pig model. Mouse model. Rat Atherosclerosis, 907
model Avoparcin
.Antibiotic resistance glycopeptide-resistant enteroeocci and, 849
aminoglycosides, and Acinetohacter spp., 455
aminoglycosides, and Enterobacteriaceae, 1019 Bactec system, 821
extended-spectrum /^-lactamases of K. pneumoniae, 201 Bacteraemia
frequency of, 751 E odoratum, 183
gentamicin, and 5. aureus, 173 group B streptococci, 649
glycopeptide-resistant enterococci (GRE), 849 Bacteriophages
in hospitals: surveillance and molecular typing, 1037 for typing Campylobacters, characterisation, 123
House of Lords Select Committee report, 749, 751 Bacteroides spp.
isoniazid. rifampicin and M. tuherculosis, 189 enzyme production and genotoxicity, 407
macrolide-lincosamide, and S. hyicus, 63 in liver and spleen abscesses, 1075
meropenem susceptibility of P aeruginosa, 653 Balamuthia mandrillaris
methicillin and 5. aureus, 341, 607, 705, 1037 i,solation of. 937, 939
mupirocin, and 5. aureus, 829 BCG vaecine, 947
overview of problems, 751 Bifidobacteria
rifampicin and P. fiuorescens, 197 enzyme produetion and genotoxicity, 401
role of education, 751 protective role against necrotising enterocolitis, 391
of S. aureus, 341 Biliary tract infection in cryptosporidiosis, 71
S. marcescens, 1105 Biofilms
1145
1146 SUBJE-CT INDEX
formation by alhicaiis, 253 pathogenicity of C. krusei. 1047
grow th of G. vaginalis and L. acklophiliis in, 401 selective medium, 1027
inhibition by biosurfactant, 1081 use of CHROMagar for identification, 623
Sorbarod system, 401 CAPD peritonitis, 265
Biosurfactant, 1081 Capnocytophaga ocliracea
Biotin purification of immunosuppressive factor, 1087
inhibition of enhanced toxin production by C. difficile, 767 Capsule
Bite wounds of group B streptococci, 717
bacteriology, antimicrobial susceptibility and therapy, 95 of S. marcescens, 1097
Black-pigmented anaerobes of S. pyogenes, 655
bacteriocin-like activity, 585 Carbon source utilisation by B. bronchiseptica. 761
BOOK REVIEWS Cardiovascular disease, 907
Analytical Parasitology (edited by M. T. Rogan), 184 Catheter-associated infections
Antibiotic Resistance: Origins, Evolution, Selection and Spread F. odoratum, 183
(edited by D.J. Chadwick and J. Goode), 185 Cell culture
Bacteria in Biology, Biotechnology and Medicine, 4th edition adherence of H. pylori to gastric epithelial cells, 505
(P. Singleton), 369 adherence of P. aeruginosa to tracheal cells, 129
Cases in Medical Microbiology and Infectious Diseases, 2nd adherence to and invasion of HEp-2 cells by group A streptococci,
edition (P. H. Gilligan, M. L. Smiley and D. S. Shapiro), 843 899
CMV-Related Immunopathology (edited by M. Schob, H. F. differentiation of genogroups of Ehrlichia. 235
Rabenau, H. W, Doerr and J. Cinatl), 845 effect of conditions on adherence of MRSA, 705
Current Clinical Topics in Infectious Diseases, volume 17 (edited persistence of C. trachomatis in U937 cells, 141
by J. S. Remington and M. N. Swartz), 843 vacuolation of HeLa cells by M. penetrans, 915
Infection and Environment (C. Kaplan), 844 Cervical cancer, 371
Lecture Notes on Medical Microbiology (T. Elliott, M. Hastings Chancroid, 1023
and U. Desselberger), 185 Children, infections in, 943
Managing HIV (edited by G. Stewart), 369 bacterial meningitis, 949, 957, 961
Microbiology (T. J. J. Inglis), 369 bronchiolitis, 957
Modeling Disease Transmission and Its Prevention by Disinfection classifying, in intensive eare unit, 970
(edited by C. J. Hurst), 185 community acquired: epidemiology and surveillance, 955
Molecular and Diagnostic Procedures in Mycoplasmology Volume comparison of incubation time and earrier state, 970
1: Molecular Characterization (edited by S. Razin and J.G. cystic fibrosis, management of chest infection, 969
Tully), 184 dengue and other haemorrhagic fevers, 952
Molecular Genetics of Bacteria (L. Snyder and W. Champness), detection of P. carinii, 329
844 diphtheria, 953
Notes on Medical Virology, llth edition (M. C. Timbury), 844 drug metabolism and antibiotic therapy, 975
Tuberculosis Bacteriology: Organisation and Practice, 2nd edition emerging and re-emerging, 950
(C. H. Collins, J. M. Grange and M. D. Yates), 843 epidemiological and public health perspectives, 947
Bardelella bmncliiseptica gastrointestinal, 949, 958, 963
carbon source utilisation, 761 HIV, 943, 950
Borrelia burgdorferi in immunocompromised individuals, 966
growth temperature ranges, 929 imported, 947
passive immunisation against infection, 773 malaria, 948
Breast-feeding measles, 950
HIV infection and, 945 meningococcal disease, 949, 961
Bronchiolitis, 957 tuberculosis, 954
Brucella spp. viruses and gastro-ententis, 963
ELISA for antigen deteetion, 169 Chlamydia
immune response to 25-kDa OMP of B. nielitensis, 39 C. pneumoniae in atherosclerotic lesions, 907
Brucellosis C. pneumoniae, effeets of gender and smoking on immune
anti-phosphatidylcholine antibodies and, 49 response, 441
Burkliolderia spp. C. trachomatis genital tract infection and infertility, 599
B. cepacia, outer-membrane proteins, 999 diagnosis of acute C. pneumoniae infection, 615
B. cepacia, subspecific differentiation of cystic fibrosis isolates, influence of interferon on C. trachomatis infection, 141
999 persistence of C. trachomatis in U937 eells, 141
flagellm gene variation of B. pseudomallei, 689 Cholera, 847
Chondroitin sulphates
Caffeine breath test, 976 antiviral activity, 1015
Calieiviruses CHROMagar
gastro-enteritis in children, 963 for yeast identification, 623
Calvmmalobacterium granulomatis Cidofovir
ultrastructural studies, 1069 antiviral activity, 1
CAMLiC system, 547 Clostridia
Campylobacters C. difficile, inhibition of enhanced toxin production, 767
characterisation of C. coli typing bacteriophages, 123 C. difficile toxin A binding to secretory component, 879
characterisation of C. jejuni typing bacteriophages, 123 enzyme production and genotoxicity, 407
C. jejuni, spirochaete-like movement, 521 inhibition of growth by bifidobacteria, 391
infections in children, 958 in liver and spleen abscesses, 1075
mouse model of C. jejuni infection, 799 pathogenieity in experimental necrotising enterocolitis, 391
subtyping of C. jejuni, 353 promoter of C. difficile toxin B gene, 309
Candida spp. typing of environmental C. difficile, 117
C. albicans, antifungal activity of IL-2-activated Collagen-binding protein
lymphocytes, 1007 of A. Itydrophila, 417
C. albicans, biofilms and extracellular matrix, 253 Colon
C. albicans, phospholipase activity and virulence, 99 bacterial enzyme production and genotoxicity, 407
C. albicans, synergy of GM-CSF with fluconazole, 359 Computerised surveillanee, 958
inhibition of adhesion by surlactin, 1081 Confocal laser scanning microscopy, 915
interactions with platelets, 103 Copro-antigens of Echinococcus spp., 281
pathogenicity of C. albicans, 1047 Corynebacterium urealyticum
SUBJECT INDEX 1147
selective medium for, 79 aminoglycoside resistance in. 1019
Cryptdins, 941 Enterobacter spp.
Ciyptospohdium panum E. aerogenes, antibiotic resistance in hospitals, 1037
model of biliary tract infection. 71 E. cloacae, antibiotic resistance in hospitals, 1037
Culture media Enterococci
continuous automated mycobacterial liquid culture E. j'aecalis, inhibition of adhesion by surlactin. 1081
system (CAMLiC), 547 E. j'aecium, antibiotic resistance in hospitals, 1037
for diagnosis of chancroid, 1023 glycopeptide-resistant, 849
effect on adherence of MRSA, 705 plasmids, 849
effect of zinc on meropenem susceptibility of P aeruginosa. 653 treatment of infections, 858
evaluation of systems for mycobacteria, 821 Enterohaemolysins
ground red hot pepper agar for Candida spp., 1027 of E. coli, 1035
inhibition of enhanced toxin production by C. difficile, 767 Enterotoxins
selective for C. urealyticum, 79 E. coli heat-stable (EAST-1). 889
transport and isolation of A. actinomycetemcomitans, 14'i S. aureus, 265, 335
use of CHROMagar for yeast identification. 623 Enzyme immunoassay
viscosity, and motility of C. jejuni, 521 diagnosis of C. pneumoniae infection. 615
Cystic fibrosis, 129, 969, 999 PCR-based, 615
Cytokines Enzymes
antifungal activity, 1007 bacterial production and genotoxicity in colon, 407
induction of release by S. aureus, 533 Epidemiology
Cytomegalovirus aminoglycoside resistance in Acinetobacter spp., 455
antiviral activity of antibacterial factors in human milk, 1015 characterisation of campylobacter-typing bacteriophages. 123
community-acquired paediatric infections, 955
Defensins, 941 Echinococcus spp., 281
Dengue, 952 genetic typing of Salmonella Enteritidis, 427
Diarrhoea glycopeptide-resistant enterococci in hospitals, 854
C. jejuni infection in mouse model, 799 HIV infection in children, 944
enteropathogenicity markers in E. coli, 781 imported infections in children, 947
heat-stable enterotoxin of E. coli (EAST-1). 889 PCR-based typing of A. hydrophila, 499
pathogenicity of enteropathogenic E. coli, 283 plasmid profile analysis of Salmonella Typhimurium DT 204c, 483
viral gastro-enteritis in children, 963 P. nndtocida infections in pigs, 679
Diphtheria, 953 Salmonella Enteritidis repeat element (SERE). 489
DNA serotype variation in 'S. milleri' group. 435
characterisation of diarrhoeagenic E. coli clones, 227 subtyping of C. jejuni, 353
epidemiological typing of A. hydrophila, 499 tracking antibiotic resistance in hospitals, 1037
evaluation of M. tuberculosis growth by PCR, 933 typing of environmental C. difficile isolates, 117
identification of Helicobacter spp., 695 typing of Legionella spp., 667
macrorestriction analysis of K. pneumoniae, 201 Escherichia coli
molecular analysis of S. aureus gentamicin resistance, 173 bactericidal activity of monoglycerides, 383
molecular epidemiology of aminoglycoside resistance in Acineto- characterisation of diarrhoeagenic clones, 227
bacter spp., 455 enteroaggregative (EAggEC). 889
molecular probes for detection of pathogenic fungi, 811 enterohaemolysin production, 1035
molecular typing of MRSA, 341 enterohaemorrhagic (EHEC), 227, 1039
polymerase-based PCR amplification, effect of inhibitors, 1131 enteropathogenic (EPEC). 227, 283, 781
RAPD analysis of A. hydrophila, 499 enteropathogenicity markers and diarrhoeal disease, 781
Salmonella Enteritidis repeat element (SERE), 489 enzyme production and genotoxicity, 407
viruses, activity of acyclic nucleoside phosphonates, 1 expressing 25-kDa OMP of B. melitensis, 39
see also Genes haemolytic uraemic syndrome. 1039
heat-stable enterotoxin (EAST-1) and diarrhoea, 889
Echinococcus spp. inhibition of adhesion by surlactin, 1081
importance of zoonotic infection, 281 in liver and spleen abscessed, 1075
vaccine, 281 pathogenicity in children, 283
Education role of serotype 0157:H7 in human disease, 1039
control of antimicrobial drug resistance, 751 verocytotoxigenic (VTEC), 1035
Ehrlichiae Exoenzymes
granulocytic ehrlichiosis, 475 of P aeruginosa, 303
taxonomy, 475 Exotoxins
ultrastructural differentiation of genogroups, 235 of coagulase-negative staphylococci. 577
Elderly patients. 649 of 5. pyogenes, 655
Electron microscopy
C. albicans biofilms and extracellular matrix, 253 Flagellin gene variation
differentiation of genogroups of Ehrlichia, 235 of B. pseudomallei, 689
persistence of C trachomatis in U937 cells, 141 Flavobacterium odoratum
scanning, 253 catheter-associated bacteraemia. 183
transmission, 141 Fluconazole
ultrastructure of C. granulomatis, 1069 synergy in candidacidal activity, 359
ultrastructure of H. trogontum, 513 Fluid accumulation
Electrophoresis Salmonella Typhimurium-induced, 151
pulsed-field gel, 201, 341, 353, 659, 689, 993, 999 Fungi
ELISA pathogenic, molecular probes for detection, 811
antibody response in S. aureus septicaemia, 217 see also Specific fungi
anti-phospholipid antibodies in brucellosis, 49 Fusobacterium spp.
brucella antigen detection, 169 in liver and spleen abscesses. 1075
detection of copro-antigens of Echinococcus spp., 281
diagnosis of acute C. pneumoniae infection, 615 Gangliosides
Endosymbiosis antiviral activity, 1015
of ‘free-living’ amoebae, 11, 937, 939 Gardnerella vaginosis
Enterobacteriaceae growth in Sorbarod biofilms, 401
1148 SUBJECT INDEX
Gastritis, 695, 863, 1123 normal, 966
Gastro-enteritis, viral, 963 to .4. actinomycetemcomitans in periodontitis, 569
Gastrointestinal infections to B. melitensis 25-kDa OMP, 39
in children, 949, 958 to C. parvum biliary tract infection, 71
Gender to heat-shock proteins in streptococcal diseases, 711
immune response to C. pneumoniae, 441 to S. pyogenes, 655
Genes Immunisation
analysis of C. difficile toxin B promoter, 309 of HIV-infected patients, 947
detection of S. aureus toxin genes, 335 mice against P. aeruginosa, 295, 303
enun gene sequence based on S. pyogenes subtyping, 893 passive, against Lyme disease spirochaetes, 773
flagellin gene variation of B. pscudomallei, 689 Immunoassay
genetic differentiation of P. mulloeida, 679 detection of MRSA. 607
genotyping of hepatitis C virus, 643 PCR-based. 607
implications of genome sequencing, 375 see also Enzyme immunoassay
location of S. aureus mupirocin resistance gene, 829 Immunocompromised patients
mutations in ermC translational attenuator, 63 causes of defects. 967
Genital tract infection infections in children. 966
C. trachomatis and infertility, 599 respiratory virus infections in, 561
Genital ulcer disease, 1023, 1069 Immunofluorescence assay
Genome sequencing, 375 diagnosis of acute C. pneumoniae infection, 615
Genotoxicity persistence of C. trachomatis in U937 cells, 141
enzyme production by intestinal bacteria, 407 Immunoglobulins
Gentamicin binding of C. difficile toxin A to secretory IgA, 879
influence on growth of /.. monocytogenes, 211 Immunohistochemistry
resistance of S. aureus, 173 detection of C. pneumoniae, 907
Glycopeptides Immunosuppression
resistant enterococci, 849 pathogenicity of C. krusei and, 1047
Granulocyte-macrophage colony-stimulating factor P. carinii infection in rat model, 543
in killing of C. albicans, 359 Imported infections, 947, 955
Granulocytic ehrlichiosis, 475 Infection control
Granulomas antimicrobial dnig resistance and. 751
role of IFN-y in fonnation, 871 imported paediatric infections, 947. 955
Guinea-pig model population movements and, 847
H. pylori gastritis, 1123 Infertility
C. trachomatis infection and, 599
Uaemolysins Inflammatory response
of coagulase-negative staphylococci, 577 to H. pylori infection, 1123
M. avium complex, 365 to A/, avium infection of gut mucosa, 725
Haemolytic uraemic syndrome, 1039 Influenza viruses
Haemophilus spp. infections in immunocompromised patients, 561
characterisation of non-capsulate //. influenzae, 1031 influenza A. effects of inhibitors in PCR amplification. 1131
H. ducreyi, laboratory diagnosis of chancroid. 1023 Insertion sequence 1S2WJ
H. ducreyi, sampling technique, 1023 profiles in Salmonella, 791
H. influenzae, genome sequencing. 375 Intensive care units
//. influenzae, paediatric meningitis. 957 classifying infections: incubation time and carrier state. 970
non-typable H. influenzae, P5 outer-membrane protein, 1059 epidemiology of antibiotic resistance, 1037
Haemorrhagic fevers. 952 meningococcal disease and, 962
Heat-shock proteins Interferon-j’
of S. pyogenes, 711 in antifungal activity of lL-2-activated lymphocytes. 1007
Helicobacter spp. C. trachomatis infection and, 141
animal models of H. pylori gastritis, 863, 1123 role in granuloma formation, 871
H. pylori, monoclonal antibody to inhibit adhesion, 505 Interleukins
identification by PCR. 695 IL-2-activated lymphocytes, antifungal activity. 1007
immune response in H. pylori gastritis, 863. 1123 release of lL-8 from neutrophils, 55
ultrastructure of H. trogontum, 513 International Health Regulations, 847
Hepatitis C virus Intestinal loops
distribution of genotypes in Korea. 643 Salmonella Typhimurium-induced fluid accumulation. 151
Histophilus ovis Intestinal microflora
characterisation by PCR methods, 987 translocation and C. difficile infection, 591
plasmid profile analysis. 987 Intestine, small
HIV infection peptide mediators of innate immunity, 941
in children, 943, 950 Iron-binding proteins
epidemiology, 944, 950 of N. meningitidis, 257, 757
vertical transmission. 944 Iso-electric focusing. 201
Human papillomaviruses Isoniazid resistance
cerx'ical cancer and, 371 in A/, tuberculosis, 189
detection of, 371
Hydatidosis, 281 JC virus
5-Hydroxytryptamine in African PML, 733
Salmonella Typhimurium-induced fluid accumulation and, 151
Kanamycin
Immune response resistance of Enterobacteriaceae, 1019
animal models of H. pylori gastritis, 863, 1123 Keratoconjunctivitis, epidemic, 91
bacterial conjugate vaccines and, 563 Klebsiella pneumoniae
gender, smoking and C pneumoniae infection, 441 antibiotic resistance in hospitals. 1037
IFN-y and granuloma formation. 871 extended-spectrum /1-lactamases, 201
infections in immunocompromised children, 966 in liver and spleen abscesses. 1075
neutrophils in L. monocytogenes infection, 55
neutrophils in Y. entemcolitica infection, 55 Labour, premature
SUBJECT INDEX 1149
associated with M. hominis infection. 179 immune response to B. melitensis 25-kDa OMP, 39
/?-Lactamases immunisation against P. aeruginosa, 295, 303
extended-spectnim, of K. pneumoniae, 201 M. avium infection of gut mucosa, 725
Lactobacilli pathogenicity of C. albicans, 99
L. acidophilus, enzyme production and genotoxicity, 407 protective effects of S. houlardii, 111
L. acidophilus, growth in Sorbarod biofilms, 401 pulmonary clearance of M. catarrhalis, 159
L. acidophilus, inhibition of adhesion by surlactin. 1081 role of IFN-y in granuloma formation, 871
protective effect against C. difficile infection. 591 septic arthritis, group B streptococci, 717
Lactoferrin Serpidina hyodysenteriae infection, 275
antistaphylococcal properties, 837 ultrastructural studies of H. trogontum, 513
antiviral activity, 1015 K enterocolitica-indxiced thymocyte apoptosis. 447
Lectins M protein
interactions with oral streptococci. 29 of S. pyogenes, 655, 893
Legionella spp. Mucosa
endosymbiosis and ‘free-living’ amoebae, 11, 937, 939 C. difficile and bacterial translocation, 591
identification and epidemiological typing, 667 mouse model of .V/. avium infection, 725
serological diagnosis of pneumonia. 325 Mupirocin
Legionnaires’ disease, 325 resistance of S. aureus, 829
Leukoencephalopathy, progressive multifocal, 733 Muscle pain, orofacial, 577
Lipopolysaccharide (LPS) Mycobacteria
A. actinomycetemcomitans, 569 diagnosis of isoniazid and rifampicin resistance in M. tuberculosis,
S', marcescens, 1097 189
Listeria monocytogenes enhanced diagnosis of tuberculosis, 547
killing mechanism in activated macrophages, 211 growth indicator tube evaluation. 821
neutrophil-mediated immune response, 55 haemolysin from M avium strains from AIDS patients, 365
Liver abscesses, microbiology, 1075 imported paediatric tuberculosis, 954
Louse-borne typhus, 847 M. avium infection of mouse gut mucosa, 725
Lyme disease, 773 ,V/. tuberculosis, evaluation of growlh by PCR, 933
Lymphocytes M. tuberculosis, IFN-y in granuloma induction. 871
function, and immunosuppressive factor of C. ochracea, 1087 Mycoplasmas
lL-2-activated, antifungal activity, 1007 AIDS-associated, 1115
Lysozyme antigenic and genomic variability of M. hominis, 659
antistaphylococcal properties, 837 comparative susceptibilities to antimicrobial agents. 1115
detection in AIDS patients by PCR. 983
Macrophages human urogenital tract species, 1115
candidacidal activity, 359 M. hominis infection and premature labour. 179
killing of L. monocytogenes, 211 iW. penetrans, protein kinase C activation, 915
Malaria, 948 ,V/. penetrans, vacuolation of HeLa cells, 915
Measles, 950 M. pneumoniae, antibiotic susceptibility, 1115
Media see Culture media Mycoses
Meningitis molecular probes for detection of pathogenic fungi, 811
bacterial conjugate vaccine development. 563
H. influenzae type b, 957 Naegleria fowleri
improving outcomes in disease, 961 in human disease, 6
N. meningitidis, 949, 957, 961 isolation and identification, 7, 11
paediatric imported infections, 949 Natural killer cells, 1007
S. pneumoniae infection, 17 Necrosis
Meningococci see Neisseria meningitidis intestinal cells and M. avium infection, 725
Meropenem Necrotising enterocolitis. 391
susceptibility of P. aeruginosa, 653 Neisseria spp.
Methiciilin-resistant S. aureus, 341, 607, 705, 1037 carriage of an outbreak strain of N. meningitidis, 993
Micro-immunofluorescence assay N. meningitidis, development of conjugate vaccines, 563
diagnosis of acute C. pneumoniae infection, 615 N. meningitidis, imported infections in children, 949
Microplate agglutination test N. meningitidis, improving outcomes of disease, 961
for Legionnaires’ disease, 325 N. meningitidis, infections in children. 961
Milk, human N. meningitidis, transferrin-binding proteins. 257, 757
antibacterial factors with antiviral activity, 1015 Neomycin
binding of C. difficile to secretory component. 879 resistance of Enterobacteriaceae, 1019
Monoclonal antibodies Neonatal sepsis, 923
against Brucella spp., 169 Neutrophils
against S. pilosicoli, 317 candidacidal activity, 359
against transferrin-binding proteins, 257 phagocytosis of L. monocytogenes and K enterocolitica, 55
to inhibit adhesion of H. pylori, 505 release of interleukin-8, 55
Monocytes Nocardia spp.
candidacidal activity, 359 N. farcinica, identification and antibiotic susceptibility, 85
induction of cytokine release by S. aureus, 533 N. nova, identification and antibiotic susceptibility, 85
Monoglycerides Nosocomial infections
bactericidal activity, 383 catheter-associated F odoratum bacteraemia. 183
Moraxella (Branhamella) catarrhalis epidemiology of resistance, 1037
model of pulmonary clearance, 159 S. marcescens, 1097, 1105
outer-membrane antigen expression, 159
Motility Oral infections
of C. jejuni, 521 pathogenicity of C albicans and C. kntsei, 1047
Mouse model see also Periodontitis
C. difficile and bacterial translocation, 591 Orofacial muscle pain, 577
C. jejuni infection, 799 Oxacillin
C. panum biliary tract infection, 71 in induction of cytokine release by S. aureus, 533
C. trachomatis genital tract infection, 599 Oxygen metabolites
immune response in H. pylori gastritis, 863 in killing of L. monocytogenes, 211
1150 SUBJECT INDEX
Paneth cell «-defensins, 941 exopolysaccharides of P. aeruginosa in adherence. 129
Parainfluenza vimses Population movements
infections in immunocompromised patients, 561 infectious diseases and, 847
Pasleurella multockla Porphyromonas gingivalis
genetic differentiation, 679 in adult periodontitis, 187
porcine pneumonia and atrophic rhinitis, 679 bacteriocin-like activity, 585
PCR virulence factors, 187
amplification of influenza A virus, 1131 Prevotella spp.
characterisation of diarrhoeagenic E. coli clones, 227 in liver and spleen abscesses, 1075
characterisation of Histophilus ovis, 989 pathogenic synergy with Pept. micros, 135
characterisation of non-capsulate //. infiuenzae, 1031 P intermedia, bacteriocin-like activity, 585
detection of C. pneumoniae, 907 P. nigrescens, bacteriocin-like activity, 585
detection of mycoplasmas in respiratory tract specimens, 983 PROCEEDINGS OF THE PATHOLOGICAL SOCIETY OF GREAT
detection of P carinii infection, 329 BRITAIN AND IRELAND. 463, 1137
detection of .S', aureus toxin genes. 335 Prodigiosin production
diagnosis of C. pneumoniae infection. 615 S. marcescens, 1105
effects of inhibitors in clinical specimens, 1131 Progressive atrophic rhinitis, 679
with enzyme immunoassay, 615 Proteins
epidemiological typing of A. In Jropliila, 499 antimicrobial peptides. 941
ERIC, 227, 499 ' collagen-binding, of A. hydrophila, 417
evaluation of A/, luherculosis growth, 933 heat-shock, of S. pyogenes, 111
flagellin gene variation of B. pseudomallei, 689 M protein of 5. pyogenes, 655, 893
genetic typing of Salmonella Enteritidis. 427 outer envelope, of S. pilosicoli, 317
genotyping of hepatitis C virus. 643 outer-membrane antigen of B. melitensis, 39
identification of Helieohaeter spp., 695 outer-membrane, of B. cepacia, 999
identification of Legionella spp., 667 P5 outer-membrane, of non-typable H. influenzae, 1059
with immunoassay for detection of MRS A, 607 protein kinase C activation and M. penetrans, 915
intergenic rRNA gene sequence length polymorphism transferrin-binding, of N. meningitidis, 257. 757
analysis, 667 Providencia spp.
molecular typing of MRSA, 341 natural antibiotic susceptibility. 629
multiplex. 335, 607 Pseudomonas spp.
repetitive extragenic palindromic (REP), 1031 immunisation of mice against P. aeruginosa, 295, 303
ribotyping of C. dijficile, 117 P. aeruginosa, antibiotic resistance in hospitals, 1037
Salmonella Enteritidis repeat element (SERE), 489 P. aeruginosa in cystic fibrosis patients, 969
tracking antimicrobial drug resistance in hospitals, 1037 P aeruginosa, effects of exopolysaccharide on adherence. 129
Penicillin P. aeruginosa, exoenzyme vaccine, 303
in meningococcal disease. 961 P aeruginosa, meropenem susceptibility, 653
Peptides, antimicrobial, 941 P fluorescens, plasmid. 197
Peptostreptococeus spp. P. fluorescens, rifampicin resistance, 197
in liver and spleen abscesses. 1075 Pyrolysis mass spectrometry
P miems, pathogenic synergy with Prevoiella spp.. 135 typing of C. difficile isolates, 117
P micros, virulence of rough and smooth morphotypes. 135
Periodontitis Quails
bacteriocin-like activity of black-pigmented anaerobes, 585 model of necrotising enterocolitis. 391
immune response to A. actinomycetemeomitans, 569
mechanisms of pathogenesis. 187 Rabies, 954
Peritonitis, 265 Rat model
Phages see Bacteriophages pathogenicity of C albicans and C. krusei, 1047
Phagocytosis progression of P. carinii infection. 543
/,. monocytogenes and enterocolitica by neutrophils. 55 Red hot pepper agar, 1027
Pharmacokinetics of antibiotics, 975 Respiratory syncytial virus
Phosphatidylcholine antiviral activity of antibacterial factors in human milk. 1015
antibodies in brucellosis. 49 infections in immunocompromised patients. 561
Phospholipase activity Respiratory tract infections
of C. albicans, 99 chronic childhood: P carinii, 329
Pilus detection of mycoplasmas by PCR. 983
of A. caviae, 527 diagnosis of acute C. pneumoniae infection, 615
Plasmids management in cystic fibrosis patients, 969
aminoglycoside resistance of Enterobacteriaceae, 1019 pulmonary clearance of M. catarrhalis, 159
gentamicin resistance of S. aureus, 173 viral, in immunocompromised patients. 561
glycopeptide resistance in enterococci. 849 see also Specific disorders and organisms
macrolide-lincosamide resistance of S. hyicus, 63 Restriction endonuclease analysis
profile analysis of Histophilus ovis, 989 genetic differentiation of P. nndtocida, 679
profile analysis of Salmonella Typhimurium DT 2()4c. 483 subspecific differentiation of B. cepacia, 999
rifampicin resistance in P. fluorescens, 197 typing of adenoviruses, 91
Plastic Restriction fragment length polymorphism analysis
adherence of MRSA. 705 flagellin gene variation of B. pseudomallei, 689
Platelets genotyping of hepatitis C virus, 643
interactions with Candida spp.. 103 subtyping of C. jejuni, 353
Pneumocystis carinii Retrovirus infections
detection in children. 329 chemotherapy, acyclic nucleoside phosphonates, 1
progression of infection in rat model, 543 Reverse transcription, 1131
Pneumonia Rheumatic fever, 655
Legionnaires’ disease, 325 Ribotyping
P carinii, 329 characterisation of diarrhoeagenic E. coli clones, 227
P. multockla infection in pigs, 679 genetic typing of S. Enteritidis, 427
S. pneumoniae infection, 17 PCR. of C. difficile, 117
Polymerase chain reaction see PCR Rifampicin resistance
Polysaccharides in M. tuberculosis, 189
SUBJECT INDEX 1151
in P. fiuorescens, 197 interactions with lectins. 29
Rotavirus mouse model of septic arthritis, 717
infections in children. 958, 963 serotyping of ‘5. milleri' group, 435
speciation of isolates from neonatal sepsis, 923
Saccharomyces houlardii 5. pneumoniae, antibiotic resistance, 17
protective effect in immunosuppressed mice, 111 5. pneumoniae, development of conjugate vaccines. 563
Salmonellae S. pneumoniae in invasive disease, 17
genetic typing of serotype Enteritidis, 427 S. pyogenes rheumatic fever, 655
infections in children, 949, 958 S. pyogenes virulence factors. 655
serotype Eimsbuettel, 1S200 profile, 791 T-agglutination typing. 893
serotype Enteritidis repeat element (SERE). 489 viridans. 923
serotype Livingstone, \S2()() profile, 791 Surgical wound infection in Africa, 471
serotype Typhimurium. plasmid profile analysis of DT 204c, 483 Surlactin, 1081
serotype Typhimurium, role of 5-hydroxytryptamine in fluid Surveillance
secretion. 151 antimicrobial drug resistance and. 751, 1037
SDS-PAGE community-acquired paediatric infections, 955
antigenic and genomic variability of A/, lumiinis, 659 computerised systems. 958
Secretory response nosocomial infections. 1037
to Salmonella Typhimurium. 151 Synergy
Sepsis fluconazole in killing of C. albicans, 359
early onset neonatal, 923 pathogenicity of Prerotella spp. and Pept. micros. 135
speciation of viridans streptococci, 923
Septicaemia, S. aureus. 217, 265 Taxonomy
Serology characterisation of Campylobacter typing bacteriophages. 123
detection of brucella antigen. 169 ehrlichiae, 475
diagnosis of C. pneumoniae infection. 615 Temperature
diagnosis of legionella pneumonia. 325 growth ranges of B. burgdorferi, 929
Serotyping Thermus spp.
S. marcescens. 1097 DNA polymerases, 1131
‘5. milleri' group, 435 Thymocytes
S. pneumoniae causing invasive disease, 17 K enre/wt)/;7/£’u-induced apoptosis. 447
Serpulina spp. Tick-borne diseases
5. hyodysenteriae murine model of infection, 275 granulocytic ehrlichiosis. 475
S. pilosicoli diagnostic polyclonal and monoclonal antibodies, passive immunisation against Lyme disease spirochaetes. 773
317 Tobramycin
Serralia marcescens resistance of Enterobacteriaceae, 1019
antibiotic resistance, 1105 Toxicity
O and K serotype distributions, 1097, 1105 of antibiotics in children. 976
virulence factors, 1105 Toxic shock syndrome toxin-1. 265. 335
Shigella spp. Toxins
infections in children. 949, 958 C. difficile toxins A and B. 309, 767. 879
Silicone rubber toxic shock syndrome toxin-1, 265, 335
adhesion of uropathogenic bacteria and yeasts, 1081 see also Enterotoxins, Exotoxins
Small round structural viruses, 963 Transferrin-binding proteins
Smoking of N. meningitidis, 257, 757
immune response to C. pneumoniae and, 441 Translocation
Sorbarod biofilms, 401 mouse model of C. difficile infection. 591
Soulsby report. 749 Transport
Spirochaetes see Borrelia hurgdorf'eri of .4. actinomycetemcomilans, 743
Spleen abseesses. microbiology. 1075 Travel
Staphylococci infectious diseases and. 847, 947
adherence to plastic and cell cultures. 705 Trichomonas vaginalis
in aetiology of ehronic muscle pain. 577 growth and survival. 555
antibody response in S. aureus septicaemia, 217 Tuberculosis, 547, 954
eoagulase-negative, 577
gentamicin resistance of S. aureus, 173 Ultrastructural studies
haemolysins, 577 Calymmatobacterium granidomatis. 1069
high-level mupirocin resistance in S. aureus, 829 differentiation of genogroups of Ehrlichia. 235
macrolide-lincosamide resistance plasmid from S. hyicus, 63 //. trogontum. 513
methieillin-resistant 5. aureus (MRSA). 341, 607, 705, 958, 1037 Ureaplasma urealyticum
S. aureus, comparative phenotypic characterisation, 265 detection in specimens from AIDS patients, 983
S. aureus in cystic fibrosis patients, 969
S. aureus, detection of toxin genes, 335 Vaccines
S. aureus, induction of cytokine release, 533 against Echinococcus spp.. 281
5. aureus, in liver and spleen abscesses, 1075 against measles, 950
S. aureus, molecular typing, 341 against .V. meningitidis, 563
S. aureus, nosocomial infections, 1037 against P. aeruginosa. 303
S. aureus plasmids, 173 against 5. pneumoniae, 563
S. aureus, virulence faetors, 265 bacterial conjugate, 563
S. epidermidis, antimicrobial synergy of lactoferrin and lysozyme. role in control of infection. 751
837 Vaginosis, bacterial, 179, 401
S. epidermidis, inhibition of adhesion by surlactin, 1081 Vancomycin-resistant enterococci, 849
Streptococci Verocytotoxic E. coli, 1035
emm gene sequence based on 5. pyogenes subtyping, 893 Vibrio cholerae
group A, adherence to and invasion of HEp-2 cells, 899 bactericidal activity of monoglycerides, 383
group B bacteraemia in the elderly, 649 Virulence factors
group B capsular polysaccharides. 717 ,4. caviae, 527
group D, in liver and spleen abscesses, 1075 C. albicans, 99
heat-shock proteins of S. pyogenes, 111 enteropathogenic E. coli, 781
1152 SUBJECT INDEX
group A streptococci, 899 Xylitol
P. gingivalis, 187 protective effect against C. difficile infection, 591
S. aureus. 265
X. marcescens, 1105 Yeasts
S. pyogenes. 655 use of CHROMagar for identification, 623
Vitamin A Yersinia enlerocolitica
HIV infection and, 945 induction of thymocyte apoptosis, 447
neutrophil-mediated immune response, 55
Western blot analysis
identification of S. pilosieoli. 317 Zinc
Wound infection meropenem susceptibility of P. aeruginosa and, 653
in Africa, 471 Zoonoses: hydatidosis, 281
INDEX OF AUTHORS FOR VOLUME 47
ABU-HASAN N see ADWAN et al., 1019 BEVANGER L, BERGH K, GISNAS G, CAUGANT D A,
ADWAN K. ABU-HASAN N, AL-ASMAR H. Analysis of neomycin, FR0HOLM L O. Identification of nasopharyngeal carriage of
kanamycin, tobramycin and amikacin resistance mechanisms in an outbreak strain of Neisseria meningitidis by pulsed-field gel
gentamicin-resistant isolates of Enterobacteriaceae. 1019 electrophoresis versus phenotypic methods, 993
AGOSTINI H T see STONER et al., 733 BHAT D A see DESHPANDE et al., 365
AINSCOUGH S, KIBBLER C C. An evaluation of the cost- BIRKELUND S see JENSEN et al., 659
effectiveness of using CHROMagar for yeast identification in BISHOP K see POWELL et al., 257
a routine microbiology laboratory, 623 BISTONI F see TISSI et al., 717
ALA'ALDEEN D A see POWELL et al., 257 BLOIGU A see VON HERTZEN et al., 441
AL-ASMAR H see ADWAN et al., 1019 BLOMQVIST L .see COLQUE-NAVARRO et al., 217
ALELJUNG P see STUREGARD et al., 1123 BOLLET C see DAVIN-REGLI et al., 499
ALEX ALEYAMMA see WEST et al., 923 BOLTON F J see SAILS et al., 123
ALLISON D G see LIVESLEY et al., 999 BORCH K see TIVELJUNG et al., 695
AL-SAIF N M, O'NEILL G L, MAGEE J T, BRAZIER J S, BOROVSKY Z, TARSHIS M, ZHANG P, ROTTEM S. Protein
DUERDEN B 1. PCR-ribotyping and pyrolysis mass spectro¬ kinase C activation and vacuolation in HeLa cells invaded by
metry fingerprinting of environmental and hospital isolates of Mvcoplasma penetrans, 915
Clostridium difficile, 117 BORRI’eLLO S P .see POWELL et al., 257
AL-SAWAN RIMA ice WEST et al., 923 BOWDEN R A, CLOECKAERT A, ZYGMUNT M S, DUBRAY G.
AL-SHAMAHY H A, WRIGHT S G. Enzyme-linked immunosorbent Evaluation of immunogenicity and protective activity in
assay for brucella antigen detection in human sera, 169 BALB/c mice of the 25-kDa major outer-membrane protein
AL-WALl W 1, ELVIN S J, MASON C M, CLARK A, TRANTER H of Brucella melitensis (Omp25) expressed in Escherichia coli,
S. Comparative phenotypic characteristics of Staphylococcus 39
aureus isolates from line and non-line associated septicaemia, BRANGER C, LESIMPLE A L, BRUNEAU B, BERRY P,
CAPD peritonitis, bone/joint infections and healthy nasal LAMBERT-ZECHOVSKY N. Long-term investigation of the
carriers, 265 clonal dissemination of Klebsiella pneumoniae isolates produ¬
AMAKO KAZUNOBU see SHIGEMATSU et al., 521 cing extended-spectrum ^-lactamases in a university hospital,
ANDRADE J R C see ROSA et al., 781 201
ANDREADIS T G see POPOV et al., 235 BRAZIER J S .see AL-SAIF et al., 117
AOKI T see SUGAWARA et al., 871 BROOK 1, FRAZIER E H. Microbiology of liver and spleen
APPUHAMY S, LOW J C, COOTE J G, PARTON R. PCR methods abscesses, 1075
and plasmid profile analysis for characterisation of Histophilus BRUMMER E see NATARAJAN et al., 359
ovis strains, 987 BRUNEAU B see BRANGER et al., 201
ARAKAWA M see OHYA et al., 211 BRUN J see PETITJEAN et al., 615
ARNOLD R, KONIG W. Interleukin-8 release from human neutro¬ BUSSCHER H J see VELRAEDS et al., 1081
phils after phagocytosis of Listeria monocytogenes and Yersinia BUTEL M J, ROLAND N, HIBERT A, POPOT F, FAVRE A,
enterocolitica, 55 TESSEDRE A C, BENSAADA M, RIMBAULT A, SZYLIT O.
ASCENCIO F, WADSTROM T. A collagen-binding protein produced Clostridial pathogenicity in experimental necrotising enteroco¬
by Aeromonas hydrophila, 417 litis in gnotobiotic quails and protective role of bifidobacteria,
AUCKEN HAZEL M, PITT T L. Antibiotic resistance and putative 391
virulence factors of Serratia marcescens with respect to O and BUTT H L, DUNSTAN R H, McGREGOR N R. ROBERTS T K,
K serotypes, 1105 ZERBES MARIANN, KLINEBERG I J. An association of
AUCKEN HAZEL M, PITT T L. Different O and K serotype membrane-damaging toxins from coagulase-negative staphylo¬
distributions among clinical and environmental strains of cocci and chronic orofacial muscle pain, 577
Serratia marcescens, 1097 BYRNE M E .vee WRIGHT et al., 173
BABIC D see STEPANOVIC et al., 1027 CALDERON DE LA BARCA ANNA MARIA see LEE et al., 29
BACK A see RAJASHEKARA et al., 489 CAM ARGOS ELIZABETH R S see MOURA et al., 513
BAILLIE G S see HAWSER et al., 253 CARAGEORGIOU H see KOSTARA et al., 555
BALDWIN T J. Pathogenicity of enteropathogenic Escherichia coli, CARAPETIS J R see BENNETT-WOOD et al., 899
283 CARBON C see VERDON et al., 71
BAMBIRRA E A see PERET FILHO et al., 111 CASAO M A, LEIVA J, DIAZ R, GAMAZO C. Anti-phosphati¬
BARRETT A .see MAGEE et al., 547 dylcholine antibodies in patients with brucellosis, 49
BARTELS H see NETTELNBREKER et al., 141 CASEWELL M W see WORKMAN et al., 85
BATEMA ROSANNE P see PETSCHOW et al., 383 CASTRO ANGELA C D see LEMOS et al., 711
BAXTER A M see TEANPAISAN et al., 585 CATAMO G see PICCOLOMINl et al., 743
BAXTER 1 A see LIVESLEY et al., 999 CAUGANT D A see BEVANGER et al., 993
BEALL B, FACKLAM R R, ELLIOTT J A, FRANKLIN A R, CHABANON G see MARTY et al., 129
HOENES T, JACKSON D, LACLAIRE L, THOMPSON T, CHAl Y G see PARK et al., 643
VISWANATHAN R. Streptococcal emm types associated with CHAMOREY E .see DAVIN-REGLI et al., 499
T-agglutination types and the use of conserved emm gene CHANDRASEKARAN S, LALITHAKUMARI D. Plasmid-mediated
restriction fragment patterns for subtyping group A streptococci, rifampicin resistance in Pseudomonas fluorescens, 197
893 CHAVAGNAT F see MARTY et al., 129
BEIGHTON D .see WORKMAN et al., 85 CHEMIN K see MARTY et al., 129
BEMIS D A see PLCTKIN AND BEMIS, 761 CHEN K-H see LIN et al., 447
BENNETT-WOOD V R, CARAPETIS J R, ROBINS-BROWNE R M. CHEN S-M see POPOV et al., 235
Ability of clinical isolates of group A streptococci to adhere to CHEW W K, LASAITIS R M, SCHIO F A, GILBERT G L. Clinical
and invade HEp-2 epithelial cells, 899 evaluation of the Mycobacteria Growth Indicator Tube (MGIT)
BENSAADA M .see BUTEL et al., 391 compared with radiometric (Bactec) and solid media for
BERGH K see BEVANGER et al., 993 isolation of Mvcohacterium species, 821
BERMUDEZ L E see KIM et al., 725 CHIN J C see DJORDJEVIC et al., 679
BERRY P see BRANGER et al., 201 CHRISTIANSEN G see JENSEN et al., 659
BETTELHEIM K A see GOLDWATER AND BETTELHEIM, 1039 CLARK A see AL-WALl et al., 265
BETTELHEIM K A. A spectrum of verocytotoxigenic Escherichia CLOECKAERT A see BOWDEN et al., 39
coli, 1035 COLMAN G, COOKE E M, COOKSON B D, COOPER P G,
1153
1154 AUTHOR INDEX
EFSTRATIOU A, GEORGE R C. Pneumococci causing DUERDEN B 1 .see AL-SAIE et al., 117
invasive disease in Britain 1982-1990. 17 DUMLER J S .see POPOV et al., 235
COLONNA D'lSTRlA V sec- DAVIN-REGLI et a!., 499 DUNSTAN R H .see BUTT et al., 577
COLQU E-NAVARRO P. SODERQUIST B. HOLMBERG H,
BLOMQVIST L, OLCEN P, MOLLBY R. Antibody response EAMENS G J see DJORDJEVIC et al., 679
in Slaplnlococciis aureus septicaemia - a prospective study, EFSTRATIOU A .see COLMAN et al., 17
217 EIFUKU-KOREEDA HIROKO see INOUE et al., 435
CONNOR J D see PODDAR et al., 1131 ELECTRICWALA QUDSIYA .see WEST et al., 923
CONTINI C see CULTRERA et al., 983 ELLIOTT J A see BEALL et al., 893
CONTINI C. PIA VILLA MARIA. ROMANI R, MEROLLA R. ELVIN S J .see AL-WAsLI et al., 265
DELIA S, RONCHETTI R. Detection of Pneumocystis carinii ENDO T .see SZENASl et al., 5
among children with chronic respiratory disorders in the EVANS R. JOSS AWL, PENNINGTON T H, HO-YEN D O.
absence of HIV infection and immunodeficiency, 329 Progression of Pneumocystis carinii infection in an animal
COOKE E M see COLMAN et al., 17 model, 543
COOKSON B D see COLMAN et al., 17
COOKSON B D see WOODFORD et al., 829
FACKLAM R R see BEALL et al., 893
COOPER P G see COLMAN et al., 17
FAUSER C .see KAPPE et al., 811
COOTE J G see APPUHAMY et al., 987
EAUST C .see SONG AND FAUST. 309
CORKILL J E .see WINSTANLEY et al., 689
FAVRE A .see BUTEL et al., 391
CREMIEUX ANDREE .see DAVIN-REGLI et al., 499
FENG H-M see POPOV et al., 235
CRIADO M T see PINTOR et al., 757
FERREIROS C M .vee PINTOR et al., 757
CRICHTON PAMELA B. OLD D C, MORPHY HANNAH F.
PERRON L .see PINTOR et al., 757
Distribution of insertion sequence IS2Wi among different clonal
FIRTH N .see W RIGHT et al., 173
lines of the related Salmonella serotypes Livingstone and
FLUIT A C see VAN WAMEL et al., 705
Eimsbuettel. 791
FONSECA M EVANGELINA F see MOURA et al., 513
CRIPPS A W' see KYD et al., 159
FONTANA R see LIGOZZI et al., 933
CRIPPS A W’ see WEBB AND CRIPPS, 1059
FORD LORNA L see PETSCHOW et al., 383
CULTRERA R, ROULLAND-DUSSOIX DAISY. ROMANI R.
FOSTER H A .see WEST et al., 923
CONTINI C. Use of PCR to detect mycoplasma DNA in
FOX A J .see SAILS et al., 123
respiratory tract specimens from adult Hl\'-positive patients.
FRANKLIN A R .see BEALL et al., 893
983
FRAZIER E H .see BROOK AND FRAZIER. 1075
CURRAN R see TOWNER et al., 607
FREEMAN R .see MAGEE et al., 547
CURRY A see SAILS et al., 123
FRETIGNY M .see PETITJEAN et al., 615
CURTIS S. WILKINSON G W G, WESTMORELAND D. An
FREYMUTH F .see PETITJEAN et al., 615
outbreak of epidemic keratisconjunctivitis caused by adenovirus
FR0HOLM L O .see BEVANGER et al., 993
type 37, 91
FRY N K. HARRISON T G. An evaluation of intergenic rRNA gene
CUTLER C W see .lOTWANI AND CUTLER. 187
sequence length polymorphism analysis for the identification of
Legionella species, 667
DALLA-COSTA LIBERA M, IRINO KINUE, RODRIGUES J. FUJll BANYO .see OUCHl et al., 907
RIVERA IRMA N G, TRABULSI L R. Characterisation of FUJIMOTO SHUJl .see SHIGEMATSU et al., 521
diarrhoeagenic Escherichia coli clones by ribotyping and ERIC- FUKUDA MINORU .see OSAKl et al., 505
PCR. 227 FURUYA N .see MATSUMOTO et al., 295, 303
DALLAS S D, ROLFE R D. Binding of Clostridium difficile toxin A FURUYA N see TATEDA et al., 325
to human milk secretory component. 879
DAUBENER W see NETTELNBREKER et al., 141 GALLAGHER M J .see WINSTANLEY et al., 689
DAVIN-RECiLl A, BOLLET C. CHAMOREY E. COLONNA GALVIN J E .see HUTTO et al., 275
D'lSTRlA V CREMIEUX ANDREE. A cluster of infections GAMAZO C .see CASAO et al., 49
due to .Aeromonas hvdrophila revealed by combined RAPD and GARRY L .see VERDON et al., 71
ERIC-PCR. 499 GASCON J .see VILA et al., 889
DE CLERCQ E. Acyclic nucleoside plussphonates; a new dimension GENE A .see VILA et al., 889
to the chemotherapv of DNA virus and retrovirus infections. 1 GEORGE R C .see COLMAN et al., 17
DE GRAAFF J see VAN DALEN et al., 135 GlAMBIAGl-DEMARVAL M .see LEMOS et al., 711
DE GRAAEE J see VAN DOORN et al., 863 GILBERT G L .see CHEW et al., 821
DE LA MAZA LUIS M see PAL et al., 599 GISNAS G .see BEVANGER et al., 993
DELIA S see CONTINI et al., 329 GIWERCMAN B .see LIVESLEY et al., 999
DESHPANDE R G, KHAN M B. BHAT D A. NAVALKAR R G. GLOCK C see PILLAY et al., 1023
Haemolysin from Mycobacterium avium complex isolates from GOLDBLATT D. Recent developments in bacterial conjugate
AIDS patients, 365 vaccines, 563
DIAZ R .see CASAO et al., 49 GOLDSTEIN ELLIE J C. New horizons in the bacteriology,
D1 BONAVENTURA G .see PICCOLOMINI et al., 743 antimicrobial susceptibility and therapy of animal bite wounds,
DICKSON T C .see KIROV et al., 527 95
DJORDJEVIC S P, EAMENS G J. HA H, WALKER M J. CHIN J C. GOLDWATER P N, BETTELHEIM K A. New perspectives on the
Demonstration that Australian Pasteurella multocida isolates role of Escherichia coli 0157;H7 and other enterohaemorrhagic
from sporadic outbreaks of porcine pneumonia are non- E. coli serotypes in human disease, 1039
toxigenic (/a\vl ) and display heterogeneous DNA restriction GOMES TAT .see ROSA et al., 781
endonuclease profiles compared with toxigenic isolates from GOMEZ J A .see PINTOR et al., 757
herds with progressive atrophic rhinitis, 679 GOODMAN J R see KIM et al., 725
DJUKIC S .see STEPANOVIC et al., 1027 GORDON A .see PORTELLl et al., 1015
DOl N see SUGAWARA et al., 871 GORRINGE A R .see POWELL et al., 257
DOUGLAS C W 1 see TEANPAISAN et al., 585 GOVAN J R W .see LIVESLEY et al., 999
DOUGLAS L JULIA see HAWSER et al., 253 GREENWOOD D. Lords a-leaping: the Soulsby report on anti¬
DOURNES J-L see MARTY et al., 129 microbial drug resistance, 749
DOYLE R J .see LEE et al., 29 GREENWOOD D. Resistance to antimicrobial agents: a personal
DRAKE D see LEE et al., 29 view, 751
DRESES-WERRINGLOER U .see NETTELNBREKER et al., 141 GRODET A .see VERDON et al., 71
DROBNIEWSKl F A, WILSON S M. The rapid diagnosis of GR0NDAHL MARIE L0UISE, JENSEN GERDA M. NIELSEN C
isonia/id and rifampicin resistance in Mycobacterium tubercu¬ G, SKADHAUGE E. GLSEN J E, HANSEN M B. Secretory
losis - a molecular story. 189 pathways in Salmonella Typhimurium-induced fluid accumula¬
DUBRAY G see BOWDEN et al., 39 tion in the porcine small intestine, 151